urinary%20incontinence
URINARY INCONTINENCE
Urinary incontinence is the complaint of involuntary urine leakage.
Stress urinary incontinence is the involuntary urine leakage on effort or exertion or when coughing or sneezing.
Urge urinary incontinence is the one associated with or immediately preceded by urgency.
Mixed urinary incontinence is the involuntary urine leakage associated with both urgency and with exertion, effort, coughing or sneezing.

Urinary%20incontinence Signs and Symptoms

Definition

Urinary Incontinence (UI)

  • Complaint of involuntary urine leakage

Stress Urinary Incontinence

  • Involuntary urine leakage on effort or exertion or when coughing or sneezing
  • Occurs during increased intraabdominal pressure that overcomes sphincter mechanism in the absence of bladder contraction
  • Irritative voiding symptoms & nocturia are absent
  • May be caused by poor pelvic support or intrinsic sphincter deficiency
  • Stress urinary incontinence in men is primarily associated w/ surgery of the prostate

Urge Urinary Incontinence

  • Involuntary urine leakage due to detrusor overactivity, associated w/ or immediately preceded by urgency
  • Patients are unable to hold back their urine when they feel the intense need to void
  • May be caused by detrusor myopathy, neuropathy, bladder CA, stones or infections

Mixed Urinary Incontinence

  • Involuntary urine leakage associated w/ both urgency & w/ exertion, effort, coughing or sneezing
  • Present when the bladder outlet is weak & detrusor is overactive

Overflow Incontinence

  • Also referred to as “incomplete emptying”, which describes the dribbling or continuous leakage associated w/ incomplete bladder emptying
  • May be caused by bladder overdistention, impaired detrusor contraction &/or bladder outlet obstruction
  • Associated symptoms include weak urinary stream, intermittency, hesitancy, frequency & nocturia

Incontinence related to reversible medical conditions

  • Transient incontinence
    • Arises from an acute medical condition affecting the lower urinary tract
    • Symptoms resolve when the medical condition is addressed & treated
  • Functional incontinence
    • Arises from chronic impairment of physical &/or cognitive functioning
    • Diagnosis of exclusion
    • Symptoms may resolve by improving patient’s functional status, treating comorbidities & changing medications

Overactive Bladder (OAB) Syndrome

  • Urgency w/ or w/o urge incontinence usually accompanied w/ complaints of frequency & nocturia

Risk Factors

Risk Factors for Urinary Incontinence (UI)

  • Irreversible factors
    • Increasing age, race, educational attainment, family history, childhood nocturnal enuresis or daytime wetting, multiparity, forceps delivery, menopause, hysterectomy, surgery for pelvic organ prolapse
  • Reversible factors
    • Body mass index >30, smoking, high caffeine intake, participation in high-impact sports, diabetes, depression, CNS disorders, recurrent UTI, constipation, drugs, pelvic organ prolapse, environmental barrier
Editor's Recommendations
Most Read Articles
Elaine Soliven, 3 days ago

Switching from efavirenz/emtricitabine/tenofovir disoproxil fumarate (EFV/FTC/TDF) to the new bictegravir/ emtricitabine/tenofovir alafenamide (BIC/FTC/TAF) regimen maintained high rates of virological suppression in adults who are living with HIV*, according to a study presented at AIDS 2020.

01 Aug 2020
Supplementation with probiotics may have positive effects in patients with type 2 diabetes mellitus (T2DM), reports a recent meta-analysis.
Stephen Padilla, 3 days ago
Pre-exposure prophylaxis (PrEP) containing either long-acting injectable cabotegravir (CAB) or tenofovir/emtricitabine (TDF/FTC) is safe and effective for transgender women (TGW) and cisgender men who have sex with men (MSM), but CAB results in a much lower HIV incidence compared to TDF/FTC, results of the HIV Prevention Trials Network (HPTN) 083 have shown.
Jairia Dela Cruz, 2 days ago
Monthly prophylaxis with the fixed-dose combination of naphthoquine-azithromycin (NQAZ) is well tolerated and confers significant protection against infection with Plasmodium parasites among individuals residing in malaria-endemic areas in Southeast Asia, as shown in the results of a phase III trial.